Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Part of paid clinical trials in Stanford, California.

Sponsor
Associazione Angela Serra per la ricerca sul cancro
Study ID
NCT03964480
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma) as a prospective collection of data to predict the prognosis of patients with the more frequent subtypes of PTCL. It is a prospective, longitudinal, international, observational study of patients with newly diagnosed peripheral T-cell lymphoma aiming to verify whether this prospective collection of data would allow achieving a more accurate information on T-cell lymphomas. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population as well as molecular markers and to explore the prognostic or predictive implications of them in PTCL. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population.

Key Dates

Start date
Oct 14, 2018
Status verified
Feb 2025
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Progression-free survival (PFS) [ Time Frame: 2 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Ranjana Advani, MD
[email protected]
+16507256456
Jessica Catherine Lam, MSc, PhD
[email protected]
+16507230437

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CA

Related Studies